Neurological Genetics tests in Dubai & UAE

Compare available Neurological Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,000.00–3,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurological Genetics test prices

Showing 61–71 of 71 matching tests.

Neurological Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4510 SCN1B Gene Generalized Epilepsy with Febrile Seizures Plus Type 1 Genetic Test This test evaluates the SCN1B gene for variants associated with Generalized Epilepsy with Febrile Seizures Plus Type 1 (GEFS+). It identifies mutations that may cause or contribute...	3 mL whole blood in EDTA (lavender-top tube), or 5 µg extracted DNA (≥10 ng/µL), or one drop blood on FTA card	10–14 business days (3–4 calendar weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN1B gene coding region", "Flanking intronic boundaries of SCN1B gene"] Parameters [] Preparation ["No fasting required", "No drug or supplement restrictions apply; continue routine antiepileptic medications"] Indications ["Diagnosis of GEFS+ type 1", "Family history of GEFS+ type 1", "Individuals with seizure phenotypes suggestive of SCN1B dysfunction"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G40.89 Clinical summary This test evaluates the SCN1B gene for variants associated with Generalized Epilepsy with Febrile Seizures Plus Type 1 (GEFS+). It identifies mutations that may cause or contribute to specific types of epilepsy.
TEST-4281 SCN2A Gene (Early Infantile Epileptic Encephalopathy Type 11) Genetic Test This genetic test detects pathogenic variants in the SCN2A gene associated with Early Infantile Epileptic Encephalopathy Type 11.	Blood (2-3 mL EDTA), Extracted DNA, or FTA Card	3–4 Weeks (Comprehensive Report)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN2A gene variants", "Pathogenic mutations"] Parameters [] Preparation ["Genetic counselling session required before sample collection", "Detailed clinical history and family pedigree needed", "Fasting is not required"] Indications ["Infants and children with early-onset seizures unresponsive to standard treatments", "Family history of EIEE11", "Need for precise diagnosis and tailored management"] Measurement technique Confirm with laboratory Codes LOINC: 83190-8 ICD-10: G40.4 Clinical summary This genetic test detects pathogenic variants in the SCN2A gene associated with Early Infantile Epileptic Encephalopathy Type 11.
TEST-4285 SCN8A Gene Early Infantile Epileptic Encephalopathy Type 13 Genetic Test This test identifies pathogenic variants in the SCN8A gene associated with Early Infantile Epileptic Encephalopathy Type 13.	Whole blood (EDTA), extracted genomic DNA, or dried blood on FTA card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN8A gene variants", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation [] Indications ["Drug-resistant epilepsy of unknown etiology", "Neonates, infants, and children with intractable seizures", "Family history of early-onset epileptic encephalopathy"] Measurement technique Confirm with laboratory Codes LOINC: 94231-8 ICD-10: G40.4 Clinical summary This test identifies pathogenic variants in the SCN8A gene associated with Early Infantile Epileptic Encephalopathy Type 13.
TEST-4243 SGCE Gene DYT11 (Myoclonus-Dystonia) Genetic Test This test evaluates the SGCE gene for mutations associated with myoclonus-dystonia syndrome (DYT11). It uses Next-Generation Sequencing (NGS) to provide a comprehensive analysis.	Peripheral Blood, Saliva (Oragene OG-500), or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SGCE gene sequence", "Pathogenic variants in SGCE gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent bone marrow transplant or active chemotherapy"] Indications ["Suspected myoclonus-dystonia syndrome (DYT11)", "Family history of myoclonus-dystonia"] Measurement technique Confirm with laboratory Codes LOINC: 97961-3 ICD-10: G24.8 Clinical summary This test evaluates the SGCE gene for mutations associated with myoclonus-dystonia syndrome (DYT11). It uses Next-Generation Sequencing (NGS) to provide a comprehensive analysis.
TEST-4219 SLC2A1 Gene GLUT1 Deficiency Genetic Test This test identifies pathogenic variants in the SLC2A1 gene, which are responsible for GLUT1 deficiency syndrome, a metabolic disorder affecting glucose transport across the blood-...	Peripheral Whole Blood or Oral Mucosa (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC2A1 gene", "Copy Number Variations (CNV) in SLC2A1"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Clinical suspicion of GLUT1 deficiency syndrome", "Drug-resistant epilepsy", "Developmental encephalopathy"] Measurement technique Confirm with laboratory Codes LOINC: 81329-1 ICD-10: E74.81 Clinical summary This test identifies pathogenic variants in the SLC2A1 gene, which are responsible for GLUT1 deficiency syndrome, a metabolic disorder affecting glucose transport across the blood-brain barrier.
TEST-5446 SLC6A3 Gene Parkinsonism-Dystonia Infantile Genetic Test This test identifies pathogenic variants in the SLC6A3 gene associated with dopamine transporter deficiency syndrome (infantile parkinsonism-dystonia). It provides definitive molec...	Whole Blood (Venous or Heel-Prick)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC6A3 gene", "Single-nucleotide variants", "Copy-number variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected dopamine transporter deficiency syndrome", "Infants presenting with early-onset parkinsonism and dystonia"] Measurement technique Confirm with laboratory Codes LOINC: 83091-6 ICD-10: G24.1 Clinical summary This test identifies pathogenic variants in the SLC6A3 gene associated with dopamine transporter deficiency syndrome (infantile parkinsonism-dystonia). It provides definitive molecular confirmation for diagnosis and management.
TEST-4945 SYNGAP1-Related Intellectual Disability (Autosomal Dominant Type 5) Genetic Test This test identifies pathogenic variants in the SYNGAP1 gene, confirming a diagnosis of SYNGAP1-related intellectual disability.	Peripheral Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants (SNVs, indels) in the SYNGAP1 gene", "Copy number variants (via alternative methods, not this test)"] Parameters [] Preparation ["Mandatory genetic counselling session before sample collection", "Inform phlebotomist if the child is on any anticoagulants"] Indications ["Suspected SYNGAP1-related intellectual disability", "Evaluation of developmental delay and epilepsy", "Assessment of autism spectrum disorder with relevant family history"] Measurement technique Confirm with laboratory Codes LOINC: 90396-6 ICD-10: F78.A Clinical summary This test identifies pathogenic variants in the SYNGAP1 gene, confirming a diagnosis of SYNGAP1-related intellectual disability.
TEST-5888 TGM6 Gene Sequencing Test for Spinocerebellar Ataxia Type 35 (SCA35), Autosomal Dominant This test identifies pathogenic variants in the TGM6 gene associated with Spinocerebellar Ataxia Type 35 (SCA35). It uses Next-Generation Sequencing (NGS) with Sanger confirmation...	Whole blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TGM6 gene", "Presence of mutations causing SCA35"] Parameters [] Preparation ["Provide detailed clinical history", "Genetic counseling with pedigree chart required"] Indications ["Diagnosis of suspected SCA35", "Genetic counseling for families with SCA35", "Predictive testing in at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G11.8 Clinical summary This test identifies pathogenic variants in the TGM6 gene associated with Spinocerebellar Ataxia Type 35 (SCA35). It uses Next-Generation Sequencing (NGS) with Sanger confirmation for high accuracy.
TEST-5571 TREM2 Gene Sequencing for Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (Nasu-Hakola Disease) Test This test analyzes the TREM2 gene for mutations associated with Nasu-Hakola disease (PLOSL). It identifies pathogenic variants causing the disorder.	Peripheral Whole Blood (3–5 mL in EDTA Lavender-Top Tube)	21–28 calendar days (3–4 weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TREM2 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed"] Indications ["Individuals with clinical suspicion of Nasu-Hakola disease (PLOSL)", "Family members of an index patient for cascade screening", "Differential diagnosis of neurodegenerative disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81424-7 ICD-10: E75.2, G31.8 Clinical summary This test analyzes the TREM2 gene for mutations associated with Nasu-Hakola disease (PLOSL). It identifies pathogenic variants causing the disorder.
TEST-5698 ULK2 Gene (Smith-Magenis Syndrome) Genetic Test This test identifies pathogenic variants in the ULK2 gene associated with Smith-Magenis syndrome.	Peripheral Whole Blood (EDTA)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ULK2 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No special preparation required", "Stay hydrated", "Wear comfortable clothing"] Indications ["Suspected Smith-Magenis syndrome", "Developmental delay with characteristic features", "Family history of SMS"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q93.89, Q87.8 Clinical summary This test identifies pathogenic variants in the ULK2 gene associated with Smith-Magenis syndrome.
TEST-5554 ZFHX4 Gene (Congenital Ptosis) Genetic Test This test identifies pathogenic variants in the ZFHX4 gene associated with congenital ptosis.	Peripheral whole blood (EDTA)	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in ZFHX4 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variants"] Parameters [] Preparation ["No specific fasting required", "Inform genetic counsellor about all medications and supplements"] Indications ["Diagnosis of congenital ptosis", "Genetic counselling for families with ptosis", "Differentiation of isolated vs. syndromic ptosis"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Q10.0 Clinical summary This test identifies pathogenic variants in the ZFHX4 gene associated with congenital ptosis.

Category overview

Neurological Genetics: overview

Securing a deep, fundamental understanding of your family's neurological blueprint allows for proactive, highly informed medical decisions that protect your long-term cognitive and motor vitality. As the core of our advanced neuro-diagnostic laboratory services, the Neurological Genetics department utilizes state-of-the-art sequencing and targeted DNA analysis to uncover the precise genetic mutations driving rare brain, spinal cord, and peripheral nerve diseases. By leveraging advanced molecular technology, this expansive profiling helps establish an absolute diagnosis for elusive conditions, safely guiding your healthcare provider in tailoring highly personalized precision medicine, supportive therapies, and proactive family planning. Trusted for clinical rigor across premier diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical accuracy, and incredibly prompt turnaround times. Take an empowered step toward targeted neurological support—schedule your neurological genetics testing in UAE, coordinate a seamless clinic or home sample collection, or connect with our specialized specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.